Statin Therapy Guidelines

Introduction to Statin Intensity

The American Diabetes Association and American College of Cardiology classify statin therapy into two main intensity categories based on LDL cholesterol reduction 1, 2

Simvastatin 20-40 mg daily achieves a 30-49% reduction in LDL cholesterol, classified as moderate-intensity statin therapy 1, 2, 3
Atorvastatin 10-20 mg is considered a moderate-intensity statin, achieving a 30-49% reduction in LDL cholesterol 1, 2
Rosuvastatin 5-10 mg is considered a moderate-intensity statin, achieving a 30-49% reduction in LDL cholesterol 1, 2
Pravastatin 40-80 mg is considered a moderate-intensity statin, achieving a 30-49% reduction in LDL cholesterol 1, 2
Fluvastatin XL 80 mg is considered a moderate-intensity statin, achieving a 30-49% reduction in LDL cholesterol 1, 2
Atorvastatin 40-80 mg is considered a high-intensity statin, achieving a ≥50% reduction in LDL cholesterol 1, 2
Rosuvastatin 20-40 mg is considered a high-intensity statin, achieving a ≥50% reduction in LDL cholesterol 1, 2

For primary prevention in diabetes patients aged 40-75 years without established cardiovascular disease, moderate-intensity statin therapy (including simvastatin 20-40 mg) is recommended by the American Diabetes Association 1
For higher-risk patients with additional cardiovascular risk factors or established atherosclerotic cardiovascular disease, high-intensity statin therapy is preferred to achieve ≥50% LDL-C reduction and target LDL-C <70 mg/dL, according to the American College of Cardiology 1
Atorvastatin 40-80 mg or rosuvastatin 20-40 mg should be used instead of simvastatin for high-intensity lipid lowering, as recommended by the American College of Cardiology 4

Exercise particular caution with simvastatin in elderly patients, especially thin or frail women, as advised by the American Geriatrics Society 3, 5
Patients of Asian descent require caution when using simvastatin, according to the American College of Cardiology 5

Simvastatin 40 mg provides approximately 41% LDL-C reduction, making it equivalent to atorvastatin 20 mg (43% reduction) in moderate-intensity therapy, as stated by the American College of Cardiology 3